Unravelling Salvage Re-irradiation for Locally Recurrent Prostate Cancer: Challenges and Complexities

Area of Science:

• Oncology
• Radiation Oncology
• Urology

Background:

• External beam radiotherapy (EBRT) followed by local recurrence of prostate cancer poses management challenges.
• Limited comparative data exists for salvage modalities, with concerns about genitourinary and gastrointestinal toxicity.
• Patient selection for salvage therapy necessitates careful evaluation of toxicity, metastatic potential, and life expectancy.

Purpose of the Study:

• To review salvage re-irradiation options for locally recurrent prostate cancer post-EBRT.
• To discuss imaging modalities for detecting local recurrence.
• To explore radioresistance mechanisms and potential novel therapies.

Main Methods:

• Review of existing literature on salvage treatments for radiorecurrent prostate cancer.
• Focus on re-irradiation techniques including brachytherapy (BT) and stereotactic body radiotherapy (SBRT).
• Discussion of advanced imaging like multiparametric MRI and PSMA PET-CT for improved detection.

Main Results:

• Salvage re-irradiation using high-dose-rate brachytherapy (HDR-BT) or SBRT demonstrates comparable biochemical control to other methods.
• These re-irradiation techniques offer more acceptable late toxicity profiles.
• Advanced imaging (MRI, PSMA PET-CT) enhances detection of local recurrence, particularly at low PSA levels.

Conclusions:

• Management of locally recurrent prostate cancer post-EBRT requires careful patient selection and consideration of available salvage options.
• Salvage re-irradiation with HDR-BT or SBRT is a viable option with favorable outcomes and toxicity.
• Further research is essential to optimize treatment strategies, ADT duration, and focal versus whole-gland approaches.